Valuation: UCB

Market Cap 4.31TCr 4.98TCr 4.04TCr 3.68TCr 6.93TCr 4,74700Cr 7.05TCr 47TCr 19TCr 2,37600Cr 19TCr 18TCr 7,92600Cr P/E 2026 *
22.7x
P/E 2027 * 18.6x
Enterprise Value 4.33TCr 5TCr 4.06TCr 3.7TCr 6.97TCr 4,77000Cr 7.08TCr 48TCr 19TCr 2,38800Cr 19TCr 18TCr 7,96500Cr EV / Sales 2026 *
5x
EV / Sales 2027 * 4.26x
Free-Float
61.59%
Yield 2026 *
0.64%
Yield 2027 * 0.66%
1 day-1.13%
1 week-0.71%
Current month+2.11%
1 month-6.68%
3 months-4.92%
6 months-17.48%
Current year-5.40%
1 week 222.1
Extreme 222.1
229.2
1 month 217.7
Extreme 217.7
255.4
Current year 217.7
Extreme 217.7
285.4
1 year 187.5
Extreme 187.5
285.4
3 years 65.68
Extreme 65.68
285.4
5 years 65.68
Extreme 65.68
285.4
10 years 55.45
Extreme 55.454
285.4
Manager TitleAgeSince
Chief Executive Officer 67 01/01/2015
Director of Finance/CFO 60 01/07/2020
Chief Tech/Sci/R&D Officer 59 01/05/2024
Director TitleAgeSince
Director/Board Member 55 01/01/2012
Director/Board Member 67 01/01/2015
Director/Board Member 56 24/04/2014
Change 5-day change 1-year change 3-year change Capi.($)
-1.13%-0.71% - - 4.98TCr
-0.54%+3.06%+42.32%-2.02% 7.96TCr
+2.55%+9.01%+1.40%+30.65% 5.27TCr
-1.46%-2.75%+19.17%+171.37% 4.98TCr
+0.08%+5.95%-47.62%-47.36% 4.68TCr
-0.10%-1.71%+57.53%-25.53% 3.01TCr
-0.51%+0.33%+47.29%+84.24% 2.45TCr
+1.39%+9.45%+139.95%-38.43% 2.42TCr
0.00%+5.81%+9.45%+194.91% 2.12TCr
-0.07%+1.49%+69.50%+163.74% 1.64TCr
Average -0.00%+4.23%+37.66%+59.06% 3.84TCr
Weighted average by Cap. -0.06%+4.49%+28.34%+43.30%

Financials

2026 *2027 *
Net sales 867.26Cr 1TCr 811.9Cr 740.8Cr 1.39TCr 95TCr 1.42TCr 9.52TCr 3.73TCr 48TCr 3.76TCr 3.68TCr 1,59400Cr 968.31Cr 1.12TCr 906.49Cr 827.12Cr 1.56TCr 1,06600Cr 1.58TCr 11TCr 4.16TCr 53TCr 4.2TCr 4.1TCr 1,78000Cr
Net income 188.64Cr 217.67Cr 176.6Cr 161.13Cr 303.22Cr 21TCr 308.31Cr 2.07TCr 811.3Cr 10TCr 817.3Cr 799.5Cr 35TCr 234.56Cr 270.66Cr 219.58Cr 200.36Cr 377.03Cr 26TCr 383.37Cr 2.57TCr 1.01TCr 13TCr 1.02TCr 994.12Cr 43TCr
Net Debt 21Cr 25Cr 20Cr 18Cr 34Cr 2.35TCr 35Cr 234.31Cr 92Cr 1.18TCr 92Cr 90Cr 3.92TCr -190.28Cr -219.57Cr -178.13Cr -162.53Cr -305.86Cr -21TCr -311Cr -2.09TCr -818.36Cr -10TCr -824.42Cr -806.46Cr -35TCr
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,000
Date Price Change Volume
12/26/12 222.30 -1.42% 151
11/26/11 €225.50 -0.04% 300
10/26/10 €225.60 +0.80% 300
07/26/07 €223.80 -2.36% 0
06/26/06 €229.20 +2.37% 0
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
226.20EUR
Average target price
286.00EUR
Spread / Average Target
+26.44%

Quarterly revenue - Rate of surprise